Search results
Showing 271 to 285 of 571 results for pregnancy
Stretta System for gastro-oesophageal reflux disease (MIB74)
NICE has developed a medtech innovation briefing (MIB) on the Stretta System for gastro-oesophageal reflux disease
outweigh any benefit prophylaxis provides. The NICE guideline on ectopic pregnancy and miscarriage recommends against anti-D prophylaxis...
Evidence-based recommendations on rimegepant (Vydura) for the acute treatment of migraine in adults.
This quality standard covers increasing the uptake of flu vaccination among people who are eligible. It describes high-quality care in priority areas for improvement.
are in evidence review V: management of unexplained vaginal bleeding in pregnancy. Source guidance details Comes from guidance Antenatal
see the rationale section on support and monitoring for women planning pregnancy or who are pregnant. Full details of the evidence and...
intervention that may positively influence the transition from maintenance of pregnancy to the onset of labour, reducing the need for...
How can fetuses at risk of intrauterine death be identified in women with diabetes?
Source guidance details Comes from guidance Diabetes in pregnancy: management from preconception to the postnatal period Number
Multiple pregnancy: antenatal care for twin and triplet pregnancies (CG129)
This guideline has been updated and replaced by NICE guideline NG137
been associated with severe hypertension, proteinuria, complications in pregnancy and progression to established renal failure. These...
baby when given to women who will deliver preterm up to 34+0 weeks of pregnancy. However, there is uncertainty about the best method of...
particularly groups for which current evidence is lacking, for example: in pregnancy and breastfeeding people 65 years and over children...
Spesolimab for treating generalised pustular psoriasis flares (TA1070)
Evidence-based recommendations on spesolimab (Spevigo) for treating generalised pustular psoriasis flares in adults.
This guideline covers assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa.
This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary and secondary care.